Sagimet Biosciences Inc.SGMTNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +76.66% | +76.95% | +10.87% | +0.88% | +1.00% |
| Weighted Average Shares Diluted Growth | +76.66% | +76.95% | +10.87% | +0.88% | +1.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +69.81% | +65.70% | -24.86% | -27.31% | -26.53% |
| Book Value per Share Growth | -1.29% | -3.31% | -34.02% | -29.61% | -30.82% |
| Debt Growth | +12.62% | +20.00% | +50.00% | -0.65% | -0.86% |
| R&D Expense Growth | +155.20% | +151.34% | +191.56% | +14.81% | -23.10% |
| SG&A Expenses Growth | -5.45% | +4.44% | +29.01% | +9.38% | +8.35% |